Skip to main content
GYRE
NASDAQ Life Sciences

Q3 Revenue Climbs to $32.9M as ETUARY Sales Grow, 2026 Outlook Reaffirmed

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$4.01
Mkt Cap
$425.195M
52W Low
$3.97
52W High
$9.14
52W Position info
1.0% above low
Off High info
56% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

GYRE is trading near its 52-week low of $3.97 (1.0% above the low) on elevated volume (1.8× avg).

Summary

Q3 revenue came in at $32.9M with a GAAP basic loss of $0.04 per share, and management kept full-year 2026 revenue guidance at $100.5M–$111.0M. The quarter's net loss was $2.5M versus $1.9M net income a year earlier, as operating expenses rose $3.2M. The growth engine is ETUARY, which sold $31.4M versus $27.7M a year earlier, though Etorel and Contiva declined. Liquidity is the soft spot: cash and investments fell to $98.8M from $116.1M at Dec. 31, 2025, a $17.3M drop the company attributes mainly to lower short-term investments. The stock sits near its 52-week low, so the affirmed outlook removes a near-term downside risk but doesn't change the story. The real swing factor is China's NMPA decision on F351, expected by end-2026 or Q1 2027.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — Gyre's Q3 2026 net loss was $2.5M versus $1.9M net income a year earlier, as operating expenses rose $3.2M.

At the time of this announcement, GYRE was trading at $4.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $425.2M. The 52-week trading range was $3.97 to $9.14. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

GYRE - Latest Insights

GYRE
Nov 05, 2026, 4:30 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.01
Real-time Price: $4.27 info
Change: +$0.260 (+6%) info
Market Cap: $485.501M info
GYRE
Aug 07, 2026, 5:00 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $6.67
Real-time Price: $4.27 info
Change: -$2.40 (-36%) info
Market Cap: $485.501M info
GYRE
Aug 07, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $6.40
Real-time Price: $4.27 info
Change: -$2.13 (-33%) info
Market Cap: $485.501M info
GYRE
Jul 15, 2026, 5:09 PM EDT
Filing Type: 8-K/A
Importance Score:
7
Price at Filing: $6.56
Real-time Price: $4.27 info
Change: -$2.29 (-35%) info
Market Cap: $485.501M info
GYRE
Jun 22, 2026, 7:16 PM EDT
Filing Type: S-3
Importance Score:
8
Price at Filing: $6.34
Real-time Price: $4.27 info
Change: -$2.07 (-33%) info
Market Cap: $485.501M info